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The objectives of the study were to translate and adapt the Subjective Handicap of Epilepsy (SHE) instrument
to Brazilian Portuguese and to determine its psychometric properties for the evaluation of quality of life in pa-
tients with epilepsy. A sample of 448 adult patients with epilepsywith different clinical proﬁles (investigation,
preoperative period, postoperative period, and drug treatment follow-up)was evaluatedwith the SHE and the
Epilepsy Surgery Inventory (ESI-55). Exploratory factorial analysis demonstrated that four factors explained
60.47% of the variance and were sensitive to discriminate the different clinical groups, with the preoperative
group having the poorest quality of life. Internal consistency ranged from 0.92 to 0.96, and concurrent validity
with the ESI-55 was moderate/strong (0.32–0.70). Test–retest reliability was conﬁrmed, with an ICC value
of 0.54 (2 days), 0.91 (7 days), and 0.97 (30 days). The SHE had satisfactory psychometric qualities for
use in the Brazilian population, similar to those of the original version. The instrument seems to be more
adequate in psychometric terms for the postoperative and drug treatment follow-up groups, and its use
should be encouraged.
© 2012 Elsevier Inc. All rights reserved.
1. Introduction
Epilepsy is a chronic neurological disease characterized by recur-
rent unprovoked epileptic seizures. The disease affects about 50 million
people worldwide, with an estimated prevalence of 200–700/100,000
inhabitants across all age ranges [1].
The disease can be treatedwith drugs (ﬁrst line) or surgery, given that
around 30% of the patients have seizures that are refractory to medica-
tions. Epilepsy is associated with high rates of limitation, disability, and
functional losses with a negative impact on quality of life (QOL). The im-
possibility to predict when and where seizures will occur may generate
permanent states of anxietywhichpatients respond towith important re-
strictions in daily life. The condition often places patients in a position of
social exclusion and causes occupational problems, in addition to the di-
rect losses related to seizures and medication side effects [2].
Many studies on health-related QOL (HRQOL) in epilepsy are lim-
ited to the analysis of the frequency of seizures as a predictive factor
of QOL improvement. Quality of life is currently understood as one's
perceptions within the framework of values of his culture, including
expectations, standards and interests, physical and psychological health,
level of independence, sociability, and relations with the environment
[3–6].
Because there is no single concept to designate what we under-
stand as QOL, there are different instruments to assess it. The most fre-
quently used today are the versions of the Quality of Life in Epilepsy
scales QOLIE-89, QOLIE-31, and QOLIE-10, theWashington Psychosocial
Seizure Inventory (WPSI), and the Side Effect and Life Satisfaction (SELS)
scale,which comprise generic and speciﬁcmeasures of QOL andare used
all over the world.
Health‐related QOL has been recently evaluated before and after
surgery for epilepsy since the current view is that the success of surgery
is not simply related to seizure control, but also to psychosocial well-
being, occupational status, leisure, and subjective life aspects. Among
the instruments that evaluate HRQOL, particularly important are the
Epilepsy Surgery Inventory (ESI-55) and the Subjective Handicap of
Epilepsy (SHE).
No ideal measure of QOL related to epilepsy has arisen, and it is still
necessary to perform psychometric studies of all currently available
instruments in order to reﬁne their adequacy. For the Brazilian popu-
lation, in particular, the instruments available are the ESI-55, validated
by Alonso et al. [7], and the QOLIE-31, validated by da Silva et al. [8].
Therefore, in this study, our focus was placed on the SHE.
Epilepsy & Behavior 24 (2012) 345–351
⁎ Corresponding author at: Department of Neuroscience and Behavior, Medical
School of Ribeirão Preto, University of São Paulo, Avenida dos Bandeirantes 3900,
CEP 14048-900, Ribeirão Preto, São Paulo, Brazil.
E-mail address: ﬂaliosorio@ig.com.br (F.L. Osório).
1525-5050/$ – see front matter © 2012 Elsevier Inc. All rights reserved.
doi:10.1016/j.yebeh.2012.04.129
Contents lists available at SciVerse ScienceDirect
Epilepsy & Behavior
j ourna l homepage: www.e lsev ie r .com/ locate /yebeh
The SHE was developed by O'Donoghue et al. [9] at the London
National Hospital for Neurology and Neurosurgery based on a literature
review and on interviews with patients and specialists in the area
in order to identify the key problems that affect the lives of epilepsy pa-
tients. The instrument contains 32 questions divided into six QOL
domains: ‘work and activities’ (eight items), ‘social and personal’ (four
items), ‘physical’ (four items), ‘self-perception’ (ﬁve items), ‘satisfaction
with life’ (four items), and ‘change’ (seven items). The items are scored
on a Likert scale with values ranging from 1 to 5. In the original psycho-
metric study, the SHE showed adequate construct validity and satisfac-
tory internal consistency in the six domains, ranging from 0.80 to 0.90.
Test–retest reliability was also adequate, ranging from 0.69 to 92 for in-
tervals of 24 h, 1 week and 4–8 weeks. It also had adequate predictive
validity, with sensitivity for the beneﬁts of successful surgery for QOL.
In view of the adequate psychometric properties of the SHE, its
rapid application and easy scoring, and the scarcity of instruments
that evaluate QOL in the population with epilepsy, the objectives of
the present study were to translate and adapt the SHE to Brazilian
Portuguese and to determine its psychometric properties as a speciﬁc
instrument for the evaluation of QOL among Brazilian subjects with
epilepsy in clinical and surgical follow-up.
2. Methods
The study consisted of four phases. Phase 1 consisted of the transla-
tion and transcultural adaptation of the SHE. The objective of phases 2
and 3was to determine the construct validity of the scale using factorial
analysis and its internal consistency, discriminant validity (phase 2),
and concurrent validity (phase 3). Phase 4 examined the test–retest
reliability of the instrument.
2.1. Translation and adaptation of the SHE to Brazilian Portuguese
The process of translation of the SHE was based on the recommen-
dations of Guillemin [10] and the Scientiﬁc Advisory Committee of
the Medical Outcomes Trust [11]. The instrument was ﬁrst translated
by an English-speaking professional who was aware of the objectives
of the study. This version was analyzed by the multidisciplinary team
of a center for the treatment of epilepsy that suggested small modiﬁ-
cations in order to improve the semantic, cultural, conceptual, and
idiomatic equivalence of the translated instrument. This ﬁnal version
was then back-translated by a bilingual translator who had no access
to the original English version and sent to the authors of the original
instrument, who considered it to be adequate.
2.2. Subjects
The subjects of the samples studied in phases 2, 3, and 4 were
recruited in the Epilepsy Surgery Center (CIREP, in the Portuguese
acronym) of the Ribeirão Preto Medical School University Hospital,
which provides inpatient and outpatient care for about 2000 epilepsy
patients from the whole country. The sample was selected by conve-
nience, and the composition of each phase is described in detail below.
Phase 2 206 patients under preoperative evaluation due to signs and
symptoms of epilepsy of difﬁcult pharmacological control
(‘Pre’ group), 120 patients in clinical follow-up one year after
surgical intervention for the treatment of epilepsy (‘Post’
group), and 46 patients with medication-controlled epilepsy
(control group).
Phase 3 38 subjects admitted to CIREP for diagnostic investigation.
Phase 4 38 subjects admitted to CIREP for diagnostic investigation
(‘DI’ group); 16 outpatients with epileptic seizures of difﬁcult
pharmacological control (‘DC’ group), and 24 subjects with
epilepsy controlled with drugs (‘C’ group).
All subjects gave written informed consent to participate in the
study. Inclusion criteria were: being under follow-up at CIREP, age
of 18 years or more, and minimum education of two years. Exclusion
criteria were: presence of Axis I psychiatric disorders (DSM-IV), men-
tal retardation detected by previous neuropsychological evaluation,
clinical or laboratory signs of intoxication by antiepileptic drugs
detected by neurological evaluation, and occurrence of a seizure during
the application of the questionnaires.
2.3. Instruments
a. Subjective Handicap of Epilepsy (SHE) — proposed by O'Donoghue
et al. [9] and translated and adapted to Brazilian Portuguese as
part of the present study. It is an instrument consisting of 32 items
scored on a ﬁve-point Likert scale whose objective is to assess the
QOL of patients with epilepsy.
b. Epilepsy Surgery Inventory (ESI-55) — proposed by Vickrey et al. [12]
and translated and validated for Brazilian Portuguese by Alonso et al.
[7]. It is an instrument consisting of 55 questions whose objective is
to assess theQOL of patientswith epilepsy, divided into the following
11 domains: general health status, functional capacity, limitation
due to physical aspects, limitation due to emotional aspects, social
aspects, pain, mental health, vitality, cognitive aspects, limitation
due to cognitive aspects, and overall QOL.
2.4. Data collection
The study was evaluated and approved by the local research ethics
committee (Protocol HCRP No. 3607/2006).
The instruments were applied by one of the investigators who is
also amember of CIREP. For outpatients, the instrumentswere applied
during the social work evaluation, which is part of the clinical protocol
of CIREP. For hospitalized patients, the instruments were applied at
the ward. The time needed to ﬁll out the instruments ranged from 20
to 60 min.
Data regarding the sociodemographic and clinical characteristics
of the samples were obtained from the medical records and from the
clinical evaluation protocol.
Different intervals were used for the retest of the three groups of
patients: 48 h for the DI group, 7 days for the DC group, and 30 days
for the C group. The instrument was completed again during hospitali-
zation or routine follow-up consultation.
2.5. Data analysis
The data were stored in a data bank and analyzed using the SAS
software, version 9, with the level of signiﬁcance set at pb0.05.
The sociodemographic and clinical characteristics of the sample
were analyzed with descriptive and parametric statistical tests
(ANOVA followed by Tukey's post-hoc test for quantitative variables
and the chi-square test for qualitative variables).
The following parameters of the SHE were analyzed:
– Construct validity— factorial structure: exploratory factorial analysis
using principal component analysis with varimax rotation in order
to assess the internal consistency and construct validity of the scales.
The criteria used for factor composition were: Kaiser–Meyer–
Olkin (KMO) index above 0.60; signiﬁcant Bartlett's sphericity test,
eigenvalues above 1; percent variance explained by the factors of
about 60%; and minimum factorial load of approximately 0.40;
– Internal consistency: Cronbach's alpha, with values above 0.60
considered acceptable [13];
– Concurrent validity: Spearman correlation coefﬁcient, with correla-
tion values of 0 indicating no association, 0.1 to 0.2 indicating mild
association, 0.3 to 0.5 indicatingmoderate association, 0.6 to 0.8 indi-
cating strong association, and >0.8 indicating total association [14];
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– Discriminant validity: correspondence maps and linear mixed-
effects model, with the dimensions presented in the map's axes
corresponding to the percentage of variance explained by each
axis [15];
For the determination of the test–retest reliability, the intraclass
correlation coefﬁcient (ICC) with a conﬁdence interval (CI) of 95%
was used for each item, with values of 0–0.20 considered negligible,
values of 0.21–0.40 as mildly, values of 0.41–0.60 as moderately, values
of 0.61–0.80 as substantially, and values >0.81 as highly adequate [16].
3. Results
3.1. Translation and adaptation of the SHE (phase 1)
The Brazilian‐Portuguese version of the SHE is available upon
request to the authors.
3.2. Subjects
The sample of phase 2 consisted of 372 subjects divided into three
groups according to clinical proﬁle, the same occurring for phase 4
subjects (n=78), whereas phase 3 subjects (N=38) were all under
diagnostic evaluation. The sociodemographic characteristics of these
samples are presented in Table 1.
Table 1 shows that the subjects of the three phases had closely
similar sociodemographic proﬁles. The subjects were proportionately
distributed in terms of sex, and the mean sample age was 31–
38.5 years. Regarding education, most subjects had only completed
elementary school. In respect to work, there was a predominance of
subjects on leave for health reasons, retired, or without paid occupa-
tional activities. Statistical analyses revealed no differences between
groups regarding the variables studied (p>0.05).
3.3. Psychometric study
3.3.1. Construct validity: factorial analysis, internal consistency and
discriminant validity (phase 2)
After analysis of the KMO index and of Bartlett's test of sphericity,
the sample was considered to be adequate for the study of the facto-
rial structure of the SHE.
Exploratory analysis according to Kaiser's criteria indicated the pres-
ence of four factors that together explained 60.47% of data variance.
Table 2 presents the distribution of the items of the SHE and of their
factorial loads on each of the factors detected.
Table 2 shows that the distribution of the items in the factorial
structure of the Brazilian version of the SHE for this sample was
similar to that of the original study [9], which detected six factors.
Factor 1 explained 45.66% of the variance and consisted of the items
related to self-perception and work/activities of the original study.
Factor 2 explained 6.42% of the variance and consisted of the items
in the ‘change’ domain. Factor 3, comprising the items of the ‘social/
personal’ and ‘satisfaction with life’ domains, explained 5.19% of the
Table 1
Sociodemographic characterization of the sample as a function of the different groups of subjects.
Subjects — phase 2 Subjects— phase 3 Subjects — phase 4
Pre (N=206) Post (N=120) Control (N=46) Total (N=38) DI (N=38) DC (N=16) C (N=24)
x SD x SD x SD x SD x SD x SD x SD
Age (years) 36.53 8.49 36.96 8.90 31.00 11.43 36.89 9.49 36.89 9.49 38.6 10.3 38.5 9.2
N % N % N % N % N % N % N %
Sex
Female 103 50.0 63 52.5 18 39.1 20 52.6 20 52.6 8 50 14 58
Male 103 50.0 57 47.5 28 60.9 18 47.4 18 47.4 8 50 10 42
Work⁎
1 62 30.1 43 35.8 26 56.5 11 28.9 11 28.9 4 25 9 38
2 10 4.8 9 7.5 6 13.0 2 5.3 2 5.3 2 12 1 4
3 134 65.1 68 56.7 14 30.4 25 65.8 25 65.8 10 63 14 58
Schooling
Elementary 137 66.5 78 65.6 25 54.4 18 47.4 18 47.4 5 31 14 58
High school 49 23.8 26 21.8 19 41.3 9 23.7 9 23.7 7 44 7 29
Higher education 20 9.7 15 12.6 2 4.4 11 28.9 11 28.9 4 25 3 13
DI = subjects hospitalized for diagnostic investigation; DC = subjects with epilepsy of difﬁcult control with medications; C = subjects with epilepsy controlled with drugs.
⁎ (1) Individuals with regular remunerated occupational activities; (2) individuals who are studying or training; (3) retired individuals on leave through the INSS or individuals
with no remunerated occupational activities.
Table 2
Distribution of the SHE items as a function of the domains of the original study and the
factors obtained (N=372).
Item SHE domains Factor 1 Factor 2 Factor 3 Factor 4
1 Work and activity 0.66
2 Work and activity 0.64
3 Work and activity 0.56
6 Work and activity 0.66
14 Work and activity 0.76
15 Work and activity 0.71
19 Work and activity 0.64
20 Work and activity 0.71
26 Change 0.73
27 Change 0.69
28 Change 0.70
29 Change 0.68
30 Change 0.78
31 Change 0.78
32 Change 0.75
21 Self-perception 0.62
22 Self-perception 0.59
23 Self-perception 0.61
24 Self-perception 0.67
25 Self-perception 0.70
8 Social and personal 0.54
9 Social and personal 0.53
10 Social and personal 0.55
11 Social and personal 0.64
4 Physical 0.70
5 Physical 0.66
17 Physical 0.48
18 Physical 0.37
7 Satisfaction with life 0.63
12 Satisfaction with life 0.50
13 Satisfaction with life 0.70
16 Satisfaction with life 0.60
347E.A. Monteiro et al. / Epilepsy & Behavior 24 (2012) 345–351
variance, and factor 4, consisting of the items in the ‘physical’ domain,
explained 3.2% of the data variance.
Regarding the internal consistency of the scale, quite expressive
alpha values were found both for the total scale (0.92–0.96) and for
the different domains (0.60–0.92), considering the different samples
of phase 2. These ﬁndings, presented in Table 3, indicate coherence
of the scale as a whole and of its domains, regardless of the sample
used.
It should be pointed out that the internal consistency analysis for
the individual items indicated that all items signiﬁcantly contributed
to increasing the consistency of the SHE since the exclusion of any
item would cause a reduction of the alpha values.
Regarding discriminant validity, the joint analysis of the three
different samples of phase 2 (total sample) through correspondence
maps (Fig. 1) indicated that it was not possible to discriminate levels
3 (“at times”) and 4 (“rarely”) of the Likert scale, whereas the more
extreme levels 1, 2, and 5 were reasonably distanced, indicating the
discriminative capacity of the instrument.
When considering the samples separately, there was a clearly low
concentration of marks close to the more favorable level of the scale
(level 5) in the Pre group, indicating that these patients, possibly
more symptomatic, had a lower QOL. Analysis of the Post and control
groups demonstrated a greater concentration of marks in the higher
levels of the Likert scale, indicating a better QOL for these less symp-
tomatic patients as a function of surgery or of pharmacological control.
Another aspect related to the discriminative capacity of the SHE
was the comparison of the different domains of the SHE and the scores
of the different sample groups using the mixed-effects linear model.
The results are shown in Fig. 2.
As seen in Fig. 2, regarding the domains ‘work and activities’, ‘phys-
ical’, ‘satisfaction’, and ‘social and personal’, there were signiﬁcant
Table 3
Cronbach's alpha coefﬁcient for the Pre, Post and Control groups and the total sample of
phase 2 as a function of the different domains of the scale.
Domains Groups
Pre
(N=206)
Post
(N=120)
Control
(N=46)
Total
(N=372)
Work and activity 0.87 0.89 0.86 0.92
Social and personal 0.79 0.80 0.73 0.82
Physical 0.60 0.64 0.72 0.72
Self-perception 0.78 0.82 0.79 0.87
Satisfaction with life 0.66 0.80 0.72 0.74
Change 0.85 0.87 0.90 0.91
General 0.93 0.95 0.92 0.96
Fig. 1. Correspondence maps for the total sample (a), the Pre group (b), the Post group (c), and the Control group (d).
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differences between the Pre and Post groups and between the Pre and
control groups, with the Pre group having the lowest scores, i.e., the
lowest QOL. No differences were detected between the Post and con-
trol groups regarding these domains. In contrast, for the self-
perception and change domains, there were signiﬁcant differences
between the Pre and Post groups and the Pre and control groups,
with the subjects in the Pre group having a lower score than all others,
and between the Post and control groups, with the Post group having
a higher score in these domains.
3.3.2. Construct validity: concurrent validity (phase 3)
The concurrent validity of the SHE was evaluated by correlation
with the ESI-55, an instrument already validated that evaluates the
QOL of patients with epilepsy. Table 4 presents the values obtained
by correlating each subscale of the two instruments.
As shown in Table 4, the statistically signiﬁcant correlations varied
from 0.32 to 0.70, classiﬁed as moderate/strong. The most expressive
correlations of the different subscales of the SHE occurred with the
subscales ‘general health status’ and ‘mental health’ of the ESI-55. In
addition, the ‘work and activity’ domain of the SHE was also strongly
correlated with the ‘social aspects’ and ‘cognitive aspects’ domains of
the ESI-55. In turn, the ‘physical’ domain of the SHE was considerably
correlated with the ‘cognitive aspects’ and ‘limitations by physical as-
pects’ domains of the ESI-55, and the ‘self‐perception’ correlated with
the ‘social aspects’ and ‘limitations by emotional aspects’ of the ESI-
55. The ‘satisfaction with life’ and ‘changes’ domains showed the low-
est number of correlations, which were also a little less expressive.
3.3.3. Test–retest reliability (phase 4)
As described previously, reliability was analyzed separately for
each group of phase 4 and at different times. For the DI group, the
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Fig. 2. Box plot representing the different domains of the SHE, with emphasis on the difference (*pb0.05) between the Pre group and the Post and Control groups.
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retest was performed two days after the ﬁrst application, and the
ICC detected for the total scale was 0.54 (IC=0.28–0.74), classiﬁed
as moderate. For the DC group, the ICC was 0.91 (IC=0.77–0.97),
classiﬁed as highly adequate, with a seven-day interval between
applications. For the C group, whose evaluations were performed with
an interval of 30 days, the ICC was 0.97 (IC=0.93–0.98). Table 5 pre-
sents the ICC values obtained for the total scale and the subscales.
4. Discussion
In view of the limited availability of instruments and their pre-
vious psychometric studies, the present investigation was carried
out in order to validate and adapt the SHE for the Brazilian context.
The process of translation and adaptation of the instrument was
based on criteria previously described in the literature [7], including
appreciation and approval by the authors of the original instrument
in order to guarantee its adequacy.
The choice of the SHE among the other instruments available in the
international literature was due to its advantages, such as a smaller
number of items, a simple and homogeneous scoring system, and its
speciﬁc evaluation of QOL in the pre- and postoperative context. The
sample used consisted of patients with different clinical proﬁles seen
at a center for the treatment of epilepsy. Data were collected in person
to enhance reliability.
The sample groups used in the different phases of the study were
large, so that the different clinical proﬁles could be covered in order
to favor a broader study of the validity of the SHE as a function of
this diversity. However, an attempt was made to control the impact
of sociodemographic variables, such as age, sex, and education, to
ensure greater homogeneity regarding these aspects.
In respect to the study of construct validity, the analysis of the
factorial structure of the SHE in the total patient sample, including
those in the Pre, Post, and control conditions, indicated the presence
of four factors. Factor 1 explained most of the variance of the data and
consisted of the association of the ‘work/activity’ and ‘self-perception’
domains, indicating that these two aspects have a more direct relation
to the ﬁndings of the original study. This result agrees with the guide-
lines of the World Health Organization (WHO), which has pointed
out the need for studies on QOL considering occupational activity and
work as relevant aspects for personal and social well-being [17–19].
Similarly, factor 3 consisted of the association of the ‘social/
personal’ and ‘satisfaction with life’ domains, indicating a more speciﬁc
association between these aspects. The remaining factors consisted
of the same items as those of the original study [9], each representing
one of the remaining domains.
These ﬁndings indicate the pertinence of the domains proposed
and the adequate construct validity of the instrument regardless of
the sociocultural context studied.
The internal consistency values of the SHEwere also quite satisfac-
tory both for the scale as a whole and for each domain in particular,
supporting the construct validity of the scale since the items and
domains showed high coherence with one another, regardless of the
sample and of the context, and the alpha values obtained in the origi-
nal study were very close to those of the present investigation [9].
Regarding the discriminant validity, the analysis of correspondence
graphs indicated that there was a greater concentration of replies
around points 1 (“very frequently”), 2 (“frequently”), and 5 (“never”,
“very unhappy”, “much worse”, “I don't need help”, “not a bit”) for the
group as a whole. Conversely, the replies to points 3 and 4 (“at times”
and “rarely”) did not differ, demonstrating that these points and their
denominations can be interpreted as synonyms or may involve subjec-
tive concepts. This hampers the interpretation of the data since
the same concept may have different meanings for each individual.
Considering the predominance of replies in the extremities of the
scale, we may hypothesize that a scale with three levels of evaluation
might determine QOL with more precision, especially because this is a
population with important cognitive impairments, such as memory
and concentration deﬁcits. Another factor that may have contributed
to the imprecision of the results was the low education of the samples
studied, in contrast to the populations studied in developed countries.
On the other hand, it should be taken into account that thismodiﬁcation
can introduce ﬂoor and ceiling effects and reduce sensitivity.
Separate analyses for each subgroup demonstrated little discrimi-
nation regarding points 3 and 4 also for the Pre group. However, in
this group, there was a clearly lower concentration of replies in
point 5, an expected result since a lower QOL could be anticipated
for this group due to its clinical proﬁle. The contrary was observed
when the Post and control groupswere evaluated, i.e., a lower concen-
tration of responses around points 1 and 2 and a greater concentration
around point 5. This ﬁnding may be related to the well-being of these
groups of patients who, with absent or infrequent symptoms, have a
better QOL and are more able to reﬂect when systematically assessing
their condition while completing the instrument [20,21].
These ﬁndings support the discriminant capacity of the SHE, as well
as its potential as a predictive instrument, favoring its use in clinical
studies and assays, especially those evaluating the impact of interven-
tions on the treatment of epilepsy.
Analyses using linearmixed-effectsmodel strongly supported the dis-
criminant capacity of the SHE and of its different domains. This analysis
showed that the score for subjects in the Pre group was lower than that
for the Post and control subjects, as reported in the literature, supporting
the negative impact of the symptoms onQOL [22–25]. On the other hand,
Post and control subjects differed only regarding the ‘self-perception’ and
‘change’ domains, with the Pre group scoring higher than the control
group, which indicates a greater inﬂuence of surgery on these domains
[4,5,25]. O'Donoghue et al. [9] determined the discriminant validity of
the SHE by evaluating the beneﬁts of epilepsy surgery in a cohort of pa-
tients, with results similar to those obtained here.
Table 4
Correlation between the domains of the SHE and ESI-55 (N=38).
SHE
ESI‐55 Work/
activity
Social/
personal
Physical Self-perception Satisfaction
with life
Changes
GHS 0.53⁎ 0.55⁎ 0.39⁎ 0.51⁎ 0.41⁎ 0.32⁎
FC 0.17 0.23 0.31 0.35⁎ 0.11 0.06
LPA 0.40 0.22 0.56⁎ 0.43⁎ 0.30 0.41⁎
LEA 0.45⁎ 0.62⁎ 0.33 0.54⁎ 0.37⁎ 0.18
SA 0.50⁎ 0.71⁎ 0.40⁎ 0.60⁎ 0.25 0.50⁎
Pain 0.32⁎ 0.47⁎ 0.46⁎ 0.33⁎ 0.25 0.17
MH 0.44⁎ 0.64⁎ 0.41⁎ 0.46⁎ 0.43⁎ 0.38
V 0.28 0.33⁎ 0.44⁎ 0.31 0.23 0.33⁎
CA 0.49⁎ 0.65⁎ 0.66⁎ 0.41⁎ 0.22 0.19
LCA 0.3 0.28 0.52⁎ 0.22 0.16 0.24
OQL 0.45⁎ 0.57⁎ 0.53⁎ 0.41⁎ 0.21 0.27
General health status (GHS); functional capacity (FC); limitation due to physical
aspects (LPA); limitation due to emotional aspects (LEA); social aspects (SA); pain;
mental health (MH); vitality (V); cognitive aspects (CA); limitation due to cognitive
aspects (LCA); overall quality of life (OQL). Bold refers to statistical signiﬁcance values.
⁎ pb0.05 signiﬁcance.
Table 5
Intraclass correlation coefﬁcient for the scale in the different samples.
DI group
(2 days)
DC group
(7 days)
C group
(30 days)
ICC 95%CI ICC 95%CI ICC 95%CI
Total 0.54 0.28–0.74 0.91 0.77–0.97 0.97 0.93–0.98
Work/activity 0.62 0.38–0.78 0.88 0.69–0.96 0.97 0.92–0.99
Change 0.48 0.19–0.69 0.88 0.70–0.96 0.91 0.79–0.96
Self-perception 0.35 0.04–0.60 0.76 0.43–0.91 0.91 0.86–0.97
Social/personal 0.24 0.08–0.52 0.90 0.74–0.96 0.83 0.64–0.92
Physical 0.65 0.42–0.80 0.61 0.17–0.84 0.81 0.60–0.91
Satisfaction with life 0.52 0.24–0.72 0.86 0.64–0.95 0.89 0.76–0.95
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The ESI-55 was used as a comparison parameter to determine the
concurrent validity of the SHE. The correlations calculated between
these two instruments were considered moderate/strong, ranging
from 0.32 to 0.70, values slightly higher than those of the original
study (0.21–0.68) [9], suggesting a signiﬁcant association between
the instruments and the concurrent validity of the SHE. The strongest
correlations were found between the domains of the SHE and ESI-55
that evaluate the same aspects, e.g., the ‘social/personal’ domain of
the SHE and the ‘social aspects’ domain of the ESI-55, with a correla-
tion of 0.70 further supporting the concurrent validity. This speciﬁc
correlation between domains was also demonstrated in the study of
O'Donoghue et al. [9]. Nonetheless, important associations were also
found between correlate domains, such as the ‘limitation due to phys-
ical aspects’ of the ESI-55 and the ‘work/activity’ domain of the SHE
(0.40). The ‘changes’ and ‘satisfaction with life’ domains of the SHE
were the ones that least correlated with the different domains of
the ESI-55. This is noteworthy, given that the impact of the different
changes in the domains assessed, whether negative or positive, would
be expected to have a direct inﬂuence on the perception of change
and global satisfaction with life.
On the other hand, we did not evaluate the divergent validity of
the SHE, especially with separate measures of depression and anxiety,
a fact that may be considered a limitation of the present study. This is
because the literature indicates that about 30–50% of individuals with
epilepsy have some type of psychiatric problem, anxiety and depres-
sion being the most frequent [26]. At the treatment center where the
study was conducted, the estimated lifetime prevalence of depression
among patients in the preoperative stage is 10%. The study of diver-
gent validity would be important to assess the inﬂuence of these
possible comorbidities on the perception of QOL.
Different results were observed in the groups regarding reliability.
For the Pre group, whose retest interval was two days, the Kappa
values were little expressive, in contrast with the ﬁndings of the
original study. We wish to point out that the score of this group
was higher in the retest than in the test despite the short interval
between them. Some possibilities can be considered to explain this
result. The ﬁrst refers to the occurrence of postictal symptoms as
part of the protocol of investigation performed during the period of
hospitalization. Ictal events are known to be followed by a period of
mental confusion and also of altered mood and physical status, a
fact that may elicit interpretation or response biases. Although great
care was taken to evaluate only patients who had not experienced
seizures immediately before the interview and whose sensory system
was fully functional, this hypothesis cannot be ruled out. Other vari-
ables that may have inﬂuenced the results are the type and frequency
of seizures suffered by the participants, the drugs used at the time of
the application of the instrument, and the side effects experienced
and described by the patients. Analysis of these variables can conﬁrm
or rule out the hypotheses raised.
The evaluation of reliability in the outpatient groups showed better
indices of agreement compared to hospitalized patients, supporting
the hypothesis raised above that the SHE may not be adequate for
hospitalized patients. However, the ﬁndings regarding the outpatient
groups attest to the reliability of the SHE in this context.
In general, the SHE proved to be adequate for use in the Brazilian
population of patients with epilepsy. For patients in acute situations
and under diagnostic investigation, the instrument showed good
validity but limited reliability, indicating limits of the instrument and
of the patient himself inherent to his clinical condition. The instrument
appears to be more appropriate in psychometric terms for the two
outpatient groups with seizures controlled by surgery or by drugs.
Considering the speciﬁcity of the instrument for patients with
epilepsy, the possible cognitive changes associated with the disorder,
as well as the low educational level of the sample studied, we believe
that a simpler scoring system based on a three-point Likert scale may
be more appropriate, increasing the psychometric quality of the SHE.
The results reported here agree with those of the original study
by O'Donoghue et al. [9], indicating that the objectives of the present
study were achieved.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.yebeh.2012.04.129.
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